Ajax-Loading

Johnson & Johnson - Diluted Average Shares

Johnson & Johnson's Fiscal Year is From January To December - All Figures are in Billions.

The item "Diluted-Average-Shares" stands at 9.70 Billion for the trailing twelve months (TTM) period ending 09/30/2025.

Johnson & Johnson's third quarter result of 2.43 Billion for the item "Diluted Average Shares" represents an increase of 0.39 percent compared to it's second quarter result.

Also, Johnson & Johnson's third quarter result of 2.43 Billion for the item "Diluted Average Shares" represents an increase of 0.03 percent compared to it's third quarter result of last year.

Looking again at the trailing twelve months series (TTM), Johnson & Johnson's third quarter result of 9.70 Billion for the item "Diluted Average Shares" represents an increase of 0.01 percent compared to it's second quarter result.


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -0.1246 percent compared to the value the year prior.
The 1 year change in percent is -0.1246.
The 3 year change in percent is -9.07.
The 5 year change in percent is -9.15.
The 10 year change in percent is -14.10.

The Serie's long term average value is 10.83 Billion. It's latest available value, on 09/30/2025, is 10.46 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 06/30/2025, to it's latest available value, on 09/30/2025, is +0.0072%.
The Serie's change in percent from it's maximum value, on 03/31/2014, to it's latest available value, on 09/30/2025, is -15.82%.

Diluted Average Shares for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Diluted Average Shares905,699,262,464.00
LogoAbbVie Inc - Diluted Average Shares399,570,305,024.00
LogoRoche Holding AG - Diluted Average Shares317,433,206,677.55
LogoAstraZeneca PLC - Diluted Average Shares280,205,508,085.11
LogoNovartis AG - Diluted Average Shares255,096,620,580.91